* Bausch Health Companies Inc BHC.TO is expected to show
a rise
in quarterly revenue when it reports results on November 2.
* The Laval Quebec-based company is expected to report a
5.1% increase in revenue to $2.151 billion from $2.05 billion a
year ago, according to the mean estimate from 5 analysts, based
on Refinitiv data.
* Refinitiv's mean analyst estimate for Bausch Health
Companies
Inc is for earnings of 90 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had risen by
about 5.0%
in the last three months.
* Wall Street's median 12-month price target for Bausch
Health
Companies Inc is $8.75, below its last closing price
of C$9.24.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2023 0.76 0.76 0.82 Beat 7.6
Mar. 31 2023 0.73 0.72 0.52 Missed -27.6
Dec. 31 2022 0.92 0.91 1.03 Beat 13.7
Sep. 30 2022 0.84 0.87 0.76 Missed -12.6
Jun. 0.89 0.89 0.56 Missed -37.3
30 2022
Mar. 31 2022 1.00 1.03 0.73 Missed -28.9
Dec. 31 2021 1.12 1.11 1.28 Beat 15
Sep. 30 2021 1.04 1.04 1.16 Beat 11
This summary was machine generated October 31 at 13:21 GMT. All
figures in US dollars unless otherwise stated